P169 Eligibility for PCSK9 inhibitors according to ESC/EAS and ACC recommendations after acute coronary syndromes

Koskinas, K C; Gencer, B.; Raeber, L; Karagiannis, A.; Nanchen, D.; Carballo, D.; Carballo, S.; Klingenberg, R.; Heg, D; Matter, C.; Luscher, T.F.; Rodondi, N; Windecker, S; Mach, F. (August 2017). P169 Eligibility for PCSK9 inhibitors according to ESC/EAS and ACC recommendations after acute coronary syndromes. European Heart Journal, 38(suppl_1), ehx501.P169. Oxford University Press 10.1093/eurheartj/ehx501.P169

[img] Text
Koskinas EurHeartJSuppl 2017_abstract.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (141kB)

Item Type:

Conference or Workshop Item (Poster)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Koskinas, Konstantinos; Räber, Lorenz; Heg, Dierik Hans; Rodondi, Nicolas and Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0195-668X

Publisher:

Oxford University Press

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

30 Jan 2018 14:59

Last Modified:

22 Oct 2019 18:28

Publisher DOI:

10.1093/eurheartj/ehx501.P169

BORIS DOI:

10.7892/boris.110533

URI:

https://boris.unibe.ch/id/eprint/110533

Actions (login required)

Edit item Edit item
Provide Feedback